<DOC>
	<DOCNO>NCT03083262</DOCNO>
	<brief_summary>Dyspareunia , painful intercourse , one commonly report complaint postmenopausal woman . One common cause dyspareunia vaginal atrophy ( VVA ) , occur &gt; 50 % postmenopausal woman . At time menopause , lack estrogen thin vaginal mucosa lesson lubrication , make sex painful . Some woman vaginal atrophy also high tone pelvic floor dysfunction ( HTPFD ) ( also know levator spasm ) . Successful treatment sexual pain require treatment vaginal atrophy HTPFD . How often vaginal atrophy HTPFD coexist study . In fact , prevalence HTPFD unknown . This likely due fact many clinician unaware existence diagnose treat . Also , sexual symptom tend underreported due embarrassment hesitation seek care . HTPFD frequently coexist condition cause pain like vaginal atrophy , endometriosis interstitial cystitis . Treatment include treating condition . If one treat , sexual pain likely continue . There several available treatment HTPFD study include physical therapy , botox intravaginal diazepam . This area clinicians may treat condition limit possibility restore normal sexual function many woman . Treating vaginal atrophy without appropriate evaluation treatment HTPFD leave cohort woman still struggle sexual pain . With good understanding relationship HTPFD vaginal atrophy , investigator hope bring awareness concern importance treat restore normal sexual function .</brief_summary>
	<brief_title>High Tone Pelvic Floor Dysfunction</brief_title>
	<detailed_description>This retrospective chart review perform identify female patient electronic medical record diagnosis vulvovaginal atrophy ( VVA ) . The record patient VVA examine demographic , symptom , answer standardize questionnaire ( e.g . Female Sexual Function Index - FSFI - routinely assess clinical evaluation ) , work-up , diagnosis , and/or treatment high tone pelvic floor dysfunction ( HTPFD ) . Symptoms HTPFD include limited pelvic pressure pain , dyspareunia . These data undergo statistical analysis .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<criteria>diagnosis vulvovaginal atrophy ( VVA ) meeting inclusion criterion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>